MYCN and neuroblastoma: Areal forward scatter measured experimentally by flow cytometry for control high-MYCN, MYCN-inhibited and rapamycin-treated (40 nM) TET21N neuroblastoma cells; shown are two biological replicates, indicated by solid and dashed lines, that were measured with the same FACS settings.